U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H18F2O2
Molecular Weight 292.3204
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIFLURANOL

SMILES

CC[C@H]([C@H](C)C1=CC(F)=C(O)C=C1)C2=CC=C(O)C(F)=C2

InChI

InChIKey=RDVXUHOSYIBGBT-ZWNOBZJWSA-N
InChI=1S/C17H18F2O2/c1-3-13(12-5-7-17(21)15(19)9-12)10(2)11-4-6-16(20)14(18)8-11/h4-10,13,20-21H,3H2,1-2H3/t10-,13-/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H18F2O2
Molecular Weight 292.3204
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Bifluranol (brand name Prostarex), a fluorinated bibenzyl anti-androgen was developed as a nonsteroidal estrogen and was studied for the treatment of benign prostatic hyperplasia. Besides, was shown that bifluranol inhibited 17 alpha-hydroxylase/C17-C20 lyase.

Approval Year

PubMed

PubMed

TitleDatePubMed
Bifluranol, a novel fluorinated bibenzyl anti-androgen, its chemistry and disposition in different animal species.
1981-05
Anti-prostatic activity of bifluranol, a fluorinated bibenzyl.
1980
Comparison of the novel bibenzyl bifluranol with diethystilboestrol: effect of aromatic fluorine substitution on metabolism [proceedings].
1978-06

Sample Use Guides

In Vivo Use Guide
Thirty five patients with bladder outflow obstruction received either Bifluranol 1.5 mg orally, t.d.s. or placebo in a double‐blind trial.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:02:03 GMT 2025
Edited
by admin
on Mon Mar 31 18:02:03 GMT 2025
Record UNII
47602X79JF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BX 341
Preferred Name English
BIFLURANOL
INN   MI  
INN  
Official Name English
BX-341
Code English
BIFLURANOL [MI]
Common Name English
BIFLUORANOL
Common Name English
bifluranol [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C242
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
Code System Code Type Description
SMS_ID
100000085904
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
FDA UNII
47602X79JF
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
INN
3795
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
MESH
C017070
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
MERCK INDEX
m1025
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY Merck Index
PUBCHEM
12850912
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
NCI_THESAURUS
C77332
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105524
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
DRUG CENTRAL
3026
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID30865725
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
CHEBI
135219
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
EVMPD
SUB05830MIG
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
CAS
34633-34-6
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
WIKIPEDIA
Bifluranol
Created by admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> AGONIST
IC50
Related Record Type Details
ACTIVE MOIETY